Migraine Headache: An Under-Appreciated Risk Factor for Cardiovascular Disease in Women.
作者信息
Elgendy Islam Y, Nadeau Stephen E, Bairey Merz C Noel, Pepine Carl J
机构信息
Division of Cardiology Massachusetts General Hospital and Harvard Medical School Boston MA.
Department of Neurology University of Florida Gainesville FL.
出版信息
J Am Heart Assoc. 2019 Nov 19;8(22):e014546. doi: 10.1161/JAHA.119.014546. Epub 2019 Nov 11.
Abstract
摘要
相似文献
1
Migraine Headache: An Under-Appreciated Risk Factor for Cardiovascular Disease in Women.
J Am Heart Assoc. 2019 Nov 19;8(22):e014546. doi: 10.1161/JAHA.119.014546. Epub 2019 Nov 11.
2
Migraine and cardiovascular diseases.
Neurol Sci. 2012 May;33 Suppl 1:S47-50. doi: 10.1007/s10072-012-1040-y.
3
Patent foramen ovale, stroke, and cardiovascular disease in migraine.
Curr Opin Neurol. 2007 Jun;20(3):310-9. doi: 10.1097/WCO.0b013e328136c22d.
4
Migraine with and without aura and risk for cardiovascular disease.
Curr Atheroscler Rep. 2008 Oct;10(5):427-33. doi: 10.1007/s11883-008-0065-4.
5
Association between Migraine and Cryptogenic Ischemic Stroke in Young Adults.
Ann Neurol. 2021 Feb;89(2):242-253. doi: 10.1002/ana.25937. Epub 2020 Nov 12.
6
Rates of Vascular Events in Patients With Migraine: A MarketScan Database Retrospective Cohort Study.
Headache. 2020 Nov;60(10):2265-2280. doi: 10.1111/head.14001. Epub 2020 Nov 3.
7
Migraine and Ischemic Stroke in Women. A Narrative Review.
Headache. 2020 May;60(5):843-863. doi: 10.1111/head.13796. Epub 2020 Apr 4.
8
Migraine with aura and patent foramen ovale: myth or reality?
Neurol Sci. 2015 May;36 Suppl 1:61-6. doi: 10.1007/s10072-015-2163-8.
9
Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
Neurology. 2023 Apr 11;100(15):716-726. doi: 10.1212/WNL.0000000000201699. Epub 2022 Dec 15.
10
[Migraine and patent foramen ovale].
Rev Neurol (Paris). 2013 May;169(5):390-6. doi: 10.1016/j.neurol.2013.01.624. Epub 2013 Apr 18.
引用本文的文献
1
The interictal transcriptomic map of migraine without aura.
J Headache Pain. 2025 May 12;26(1):109. doi: 10.1186/s10194-025-02033-z.
2
Disproportionality analysis from World Health Organization data on migraine-specific medications and cerebrovascular diseases.
Eur J Clin Pharmacol. 2025 Apr;81(4):571-581. doi: 10.1007/s00228-025-03812-y. Epub 2025 Feb 24.
3
Cardiovascular Risk Scores and Migraine Status.
JAMA Netw Open. 2024 Oct 1;7(10):e2440577. doi: 10.1001/jamanetworkopen.2024.40577.
4
Exploring the Two-Way Link between Migraines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
Thromb Haemost. 2024 Nov;124(11):1053-1060. doi: 10.1055/a-2313-0311. Epub 2024 Apr 24.
5
Gout and Migraines: Exploring the Complex Link in a 16-Year Longitudinal Study of the Korean Population.
J Clin Med. 2023 Dec 26;13(1):138. doi: 10.3390/jcm13010138.
6
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders.
J Headache Pain. 2024 Jan 4;25(1):4. doi: 10.1186/s10194-023-01700-3.
7
Migraines and cardiovascular disease: mechanisms and methodological challenges.
Nat Rev Cardiol. 2023 Dec;20(12):791-792. doi: 10.1038/s41569-023-00934-7.
8
Migraine and heart: A reality check.
Glob Cardiol Sci Pract. 2023 Aug 1;2023(3):e202320. doi: 10.21542/gcsp.2023.20.
9
Association Between Migraine and Ischemic Cardio-Cerebrovascular Disease (CCVD) and Effects of Triptans and Ergotamine on the Risk of Ischemic CCVD in Patients with Migraine in the Korean NHIS-HEALS Cohort.
Clin Drug Investig. 2023 Jul;43(7):541-550. doi: 10.1007/s40261-023-01290-7. Epub 2023 Jul 17.
10
Transcriptome-wide association study identifies novel candidate susceptibility genes for migraine.
HGG Adv. 2023 Jun 9;4(3):100211. doi: 10.1016/j.xhgg.2023.100211. eCollection 2023 Jul 13.
本文引用的文献
1
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice.
Headache. 2019 Jan;59(1):1-18. doi: 10.1111/head.13456. Epub 2018 Dec 10.
2
Ticagrelor for Refractory Migraine/Patent Foramen Ovale (TRACTOR): An open-label pilot study.
Neurology. 2018 Nov 27;91(22):1010-1017. doi: 10.1212/WNL.0000000000006573.
3
Percutaneous Closure of Patent Foramen Ovale in Migraine: A Meta-Analysis of Randomized Clinical Trials.
JACC Cardiovasc Interv. 2018 Apr 23;11(8):816-818. doi: 10.1016/j.jcin.2018.01.232.
4
Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke.
Stroke. 2018 May;49(5):1123-1128. doi: 10.1161/STROKEAHA.117.020160. Epub 2018 Apr 10.
5
Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects.
BMJ Open. 2018 Mar 27;8(3):e020498. doi: 10.1136/bmjopen-2017-020498.
6
Migraine.
Lancet. 2018 Mar 31;391(10127):1315-1330. doi: 10.1016/S0140-6736(18)30478-1. Epub 2018 Mar 6.
7
Cryptogenic Stroke and Patent Foramen Ovale.
J Am Coll Cardiol. 2018 Mar 6;71(9):1035-1043. doi: 10.1016/j.jacc.2017.12.059.
8
Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
BMJ. 2018 Jan 31;360:k96. doi: 10.1136/bmj.k96.
9
Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
J Am Coll Cardiol. 2017 Dec 5;70(22):2766-2774. doi: 10.1016/j.jacc.2017.09.1105.
10
Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
JACC Cardiovasc Interv. 2017 Nov 13;10(21):2228-2230. doi: 10.1016/j.jcin.2017.09.002.
Zotero 插件